Quality by Design Based Chromatography Technique Development and Validation for the Medicine Venetoclax (for Chronic Leukemia), in the Context of Impurities Including Degradation Products
Biomedical Chromatography · 2025
DOI: 10.1002/bmc.70072 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, 2025. Verfasst von Rajeshwari Dandabattina und 5 weiteren Autor:innen. Beteiligte Einrichtung: Bhavans Vivekananda College of Science, Humanities and Commerce, Secunderabad, Telangana, India. Hauptthemen laut MEDLINE: Sulfonamides, Bridged Bicyclo Compounds, Heterocyclic, Chromatography, Reverse-Phase. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The present research study describes the Venetoclax (VEN)‐related substances test method using RP‐HPLC/DAD techniques. It was developed and validated according to ICH Q14 and Q2(R2) guidelines. The substances were separated using an X‐Bridge Phenyl column (150 mm × 4.6 mm, 3.5 μm) and a gradient program. The mobile phase A, consist 0.02 mM Na2HPO4 (pH 8.0) buffer and acetonitrile in an 80:20 v/v ratio. Mobile phase B was prepared using a 75:25 v/v mixture of acetonitrile and a pH 8.0 buffer and well mixed. The flow rate remains constant at 1.0 mL/min, traversing an appropriate gradient program. The VEN and its impurities were detected at 280 nm, with an injection volume of 15 μL and a runtime of 130 min. Moreover, we identified proper degradation impurities and sensitivity of VEN due to forced‐degradation study experiments. The linearity and range of the testing procedure were validated by computing r 2 values over 0.999. All organic impurities were recovered at a rate of 97.6%–106.0% with a relative standard deviation of 0.11%–4.35%. A robustness test was conducted utilizing the AQbD methodology. The proposed method was stability‐indicating in nature and can be used for commercial samples in the pharmaceutical industries.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Bhavans Vivekananda College of Science, Humanities and Commerce, Secunderabad, Telangana, India.
- Department of Chemistry, GITAM School of Science, GITAM Deemed to be University, Bengaluru, Karnataka, India.
- Department of Chemistry, GITAM School of Science, GITAM Deemed to be University, Hyderabad, Telangana, India.
- School of Chemistry & Physics, College of Agriculture, Engineering & Science, Westville Campus, University of KwaZulu-Natal, Durban, South Africa.
- R&D, CHEMTEX Environmental Laboratories Inc., Port Arthur, Texas, USA.
ORCID-Profile: Karuna Sree Merugu, Haridasyam Sharathbabu, Rambabu Gundla, Naresh Kumar Katari
Zitieren
APA
Dandabattina, R., Merugu, K. S., Bandaru, L. G. R., Sharathbabu, H., Gundla, R., & Katari, N. K. (2025). Quality by Design Based Chromatography Technique Development and Validation for the Medicine Venetoclax (for Chronic Leukemia), in the Context of Impurities Including Degradation Products. Biomedical Chromatography. https://doi.org/10.1002/bmc.70072
Vancouver
Dandabattina R, Merugu KS, Bandaru LGR, Sharathbabu H, Gundla R, Katari NK. Quality by Design Based Chromatography Technique Development and Validation for the Medicine Venetoclax (for Chronic Leukemia), in the Context of Impurities Including Degradation Products. Biomedical Chromatography. 2025. doi:10.1002/bmc.70072
BibTeX
@article{Dandabattina2025,
author = {Dandabattina, Rajeshwari and Merugu, Karuna Sree and Bandaru, Lova Gani Raju and Sharathbabu, Haridasyam and Gundla, Rambabu and Katari, Naresh Kumar},
title = {Quality by Design Based Chromatography Technique Development and Validation for the Medicine Venetoclax (for Chronic Leukemia), in the Context of Impurities Including Degradation Products},
journal = {Biomedical Chromatography},
year = {2025},
doi = {10.1002/bmc.70072}
}
EUVIMED